Massive Bio

Empowering cancer patients globally through AI-based clinical trial matching

New York, United States · Founded 2015 · $32.1M raised

Headquarters
New York, New York
Employees
51–200
Founded
2015
Business Model
B2B2C
Total Funding
$32.1M
Last Round
$16.5M Series BDec 2022
Rounds
4

About

Massive Bio is a New York-based AI-driven oncology platform that connects cancer patients and their physicians to biopharmaceutical clinical trials globally. Its SYNERGY AI engine matches patients to suitable trials based on clinical and genomic data, while its Virtual Tumor Board — comprising specialists from 25 U.S. cancer research facilities — provides personalized treatment recommendations when trial matches are unavailable. The service is always free for patients and addresses the gap whereby most U.S. cancer patients receive care in community practices rather than specialized cancer centers. Massive Bio is the official matchmaking partner for all NCI-funded clinical trials.

Summary

Massive Bio is a Healthcare company based in New York, United States, founded in 2015. It has raised $32.1M in total across 4 rounds, most recently a $16.5M Series B round in Dec 2022. Investors include Revo Capital, DEG and Kenan Turnacioglu.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2022
$16.5M

Sign up to see all 4 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Massive Bio on Indexed.vc
<a href="https://indexed.vc/companies/massive-bio"><img src="https://indexed.vc/api/badge/company/massive-bio" alt="Massive Bio on Indexed.vc" width="260" height="76" /></a>